Areteia Therapeutics
Drug DiscoveryWebsite
Developer of an oral medication intended to treat eosinophilic asthma. The company's platform is focused on developing an oral drug that inhibits eosinophil maturation, showing potential to reduce inf...
Valuation
$0
Share Price
N/A
Total Raised
$425M
Last Round
Early Stage VC (Series A1)
Feb 2024
Latest Funding Round
Early Stage VC (Series A1)
Feb 12, 2024
$425M
raised
Investors
+11 other investors